225 mg subcutaneously once a month -Alternatively, 675 mg subcutaneously may be administered once every 3 months Comments: -To administer 675 mg subcutaneously, 3 consecutive subcutaneous injections of 225 mg are given. -If switching dosage options, administer the first dose of the new regimen on...
Study1(NCTincludedadultswithahistoryofepisodicmigraine(patientswith15 headachedayspermonth).Allpatientswererandomized(1:1:1)toreceivesubcutaneous injectionsofeitherAJOVY675mgeverythreemonths(quarterly),AJOVY225mgmonthly,or placebomonthly,overa3-monthtreatmentperiod.Patientswereallowedtouseacuteheadache ...
AJOVY®is indicated for prophylaxis of migraine in adults who have at least 4 migraine days per month. AJOVY is available as a 225 mg/1.5 mL single dose injection in a pre-filled syringe or, in some countries, in a pre-filled pen. Two dosing ...